The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...
The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...
Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...
News Medical on MSN1h
Study suggests a possible link between trauma and endometriosisThe study is an international collaboration based on previous research that has suggested a possible connection between ...
Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...
New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...
Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering at KAIST has captured the critical ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback